Bright Minds Biosciences (DRUG) had the highest return on April 19, 2023 by a small-cap US stock, returning 46.8%.

ASSET	DATE	% RETURN
Bright Minds Biosciences (DRUG)	4/19/2023	46.75%
Geron (GERN)	4/19/2023	20.87%
Alliance Entertainment Holding Corporation Class A Common Stock (AENT)	4/19/2023	20.61%
Trevi Therapeutics (TRVI)	4/19/2023	13.36%
Invivyd (IVVD)	4/19/2023	13.33%
National CineMedia (NCMI)	4/19/2023	13.14%
Sight Sciences (SGHT)	4/19/2023	12.51%
4D Molecular Therapeutics (FDMT)	4/19/2023	12.35%
Eyepoint Pharmaceuticals (EYPT)	4/19/2023	12.06%
Owlet (OWLT)	4/19/2023	10.63%
PepGen (PEPG)	4/19/2023	10.12%
Olema Pharmaceuticals (OLMA)	4/19/2023	9.89%
Phathom Pharmaceuticals (PHAT)	4/19/2023	9.61%
First Foundation (FFWM)	4/19/2023	9.4%
Akebia Ther (AKBA)	4/19/2023	9.28%
Vertical Aerospace (EVTL)	4/19/2023	8.99%
Alx Oncology Holdings (ALXO)	4/19/2023	8.53%
Idaho Strategic Resources (IDR)	4/19/2023	8.3%
Cognyte Software (CGNT)	4/19/2023	8.17%
UroGen Pharma (URGN)	4/19/2023	7.48%
LENZ Therapeutics (LENZ)	4/19/2023	7.17%
P3 Health Partners (PIII)	4/19/2023	7.08%
Live Oak Bancshares (LOB)	4/19/2023	7.06%
Si-Bone (SIBN)	4/19/2023	7%
Heritage Insurance Hldgs (HRTG)	4/19/2023	6.73%

Small-cap stocks are treated as having a market cap between $300M and $2B.